FAZE
发表于 2025-3-25 05:03:22
http://reply.papertrans.cn/39/3843/384258/384258_21.png
CRAFT
发表于 2025-3-25 10:24:25
http://reply.papertrans.cn/39/3843/384258/384258_22.png
FANG
发表于 2025-3-25 14:43:36
Lebenswelten als Bildungsweltenombined modality therapy for limited stage disease, and strategies for the relapsed/refractory older patient. We will also address the issues of prognosis, comorbidities, geriatric assessment, supportive care measures in older patients with DLBCL, and recommendations for assessment and allied care.
impaction
发表于 2025-3-25 17:35:13
https://doi.org/10.1007/978-3-322-95992-8ay have more significant “downstream” effects on treatment adherence and persistence. However, as more anticancer drugs become available and adopted into clinical practice (particularly oral agents), additional studies will need to address PDIs within the dynamic landscape of cancer therapeutics and
GRACE
发表于 2025-3-25 22:50:28
http://reply.papertrans.cn/39/3843/384258/384258_25.png
追逐
发表于 2025-3-26 02:29:21
http://reply.papertrans.cn/39/3843/384258/384258_26.png
曲解
发表于 2025-3-26 06:59:39
http://reply.papertrans.cn/39/3843/384258/384258_27.png
有常识
发表于 2025-3-26 08:48:17
https://doi.org/10.1007/978-3-663-02424-8, the ability to recover from major stresses on the body such as cancer treatment becomes more difficult. Varying degrees of frailty can be subtle, which explains the difficulty of distinguishing which older adults will have excess toxicity from cancer therapy and ones will tolerate it well. Thus, a
不合
发表于 2025-3-26 13:10:49
Gerd B. Achenbach,Martina Winkler-Calaminusllenge to manage in a very close future. However, the current treatment of BC in the elderly remains controversial. The purpose of this article is to review the previous literature to summarize and gather the current knowledge in order to describe the management and treatment of BC in the elderly, i
我的巨大
发表于 2025-3-26 18:57:03
http://reply.papertrans.cn/39/3843/384258/384258_30.png